New Horizon Health (HKSE:06606) General and Admin. Expense: HK$255 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06606 New Horizon Health Ltd HKSE:06606
35 GF Score
Price HK$14.14
View Full Analysis

What is New Horizon Health General and Admin. Expense?

New Horizon Health HKSE:06606 35 General and Admin. Expense is HK$255 Mil as of Jun. 2023. GuruFocus rates HKSE:06606 with a GF Score™ of 35/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. New Horizon Health's General and Admin. Expense for the six months ended in Jun. 2023 was HK$143 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2023 was HK$255 Mil.

New Horizon Health General and Admin. Expense Related Terms

New Horizon Health General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for New Horizon Health's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health General and Admin. Expense Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
General and Admin. Expense
15.71 60.31 123.11 157.38 178.22

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only 78.51 77.80 69.34 112.16 143.00
HKSE:06606
35GF Score
New Horizon Health Ltd HKSE:06606
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$255 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of HK$255 Mil mean?
New Horizon Health (HKSE:06606) has a General and Admin. Expense of HK$255 Mil as of Jun. 2023. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on New Horizon Health and its competitors.
Is New Horizon Health's General and Admin. Expense too high?
New Horizon Health's current General and Admin. Expense is HK$255 Mil. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's General and Admin. Expense compare to ABT and SYK?
New Horizon Health's General and Admin. Expense of HK$255 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on New Horizon Health and its competitors. New Horizon Health's current General and Admin. Expense is HK$255 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (HKSE:06606) has a current General and Admin. Expense of HK$255 Mil. The current General and Admin. Expense is HK$255 Mil. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For New Horizon Health (HKSE:06606), the current General and Admin. Expense is HK$255 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for HKSE:06606

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.14
Price